Hexarelin

Also known as: Examorelin

Overview

Hexarelin is a synthetic hexapeptide GHRP that potently stimulates growth hormone release via GHS-R1a. It produces one of the strongest GH pulses in its class and also exhibits cardioprotective effects, including reduced oxidative stress and improved lipid profiles. Long-term use may induce desensitization and elevate cortisol and prolactin. Hexarelin is the strongest GHRP.

Benefits

- Enhanced cardioprotection

- Muscle support

- Better lipid profile

- Growth hormone boost

Consider This Peptide If You Want To

- Stimulate GH for muscle growth, fat loss, and recovery

- Improve cardiovascular health and protect against oxidative stress

Dosage & Administration

Dosage Guidelines

Recommended Dosage

• Amount:100 mcg

• Frequency:weekdays

• Duration:8 weeks

• Rest Period:8 weeks

• Time of Day:morning

• Ingestion:subcutaneous

Administration Routes:Subcutaneous

Research Findings on Dosage:

• Subcutaneous Injection:

◦ Commonly Reported Dosage: 100 mcg, multiple injections can be given daily, 5 day on, 2 days off

◦ Duration: 4-8 weeks on, 4-8 weeks off

• Administration Notes:

◦ Administer on an empty stomach 30 minutes before eating/2 hours after eating to enhance GH release.

Mechanism of Action

Mechanism of Action

How this peptide works in the body

GH Pathway Activation:

Hexarelin binds to growth hormone secretagogue receptor 1a (GHS-R1a) in the anterior pituitary and hypothalamus, stimulating the release of growth hormone (GH). This activation triggers the cyclic AMP (cAMP) and phospholipase C (PLC) pathways, leading to the release of GH from somatotroph cells. As a result, insulin-like growth factor-1 (IGF-1) production in the liver increases, promoting muscle growth, fat metabolism, and cellular regeneration.

Cardioprotective Action:

Hexarelin reduces oxidative stress by enhancing mitochondrial superoxide dismutase (SOD) activity, which neutralizes free radicals and prevents cardiomyocyte damage. Additionally, it activates the Akt/PI3K signaling pathway, preventing cardiomyocyte apoptosis and preserving heart function. By enhancing nitric oxide (NO) production, Hexarelin improves endothelial function, vasodilation, and overall cardiac output.

Cholesterol and Lipid Regulation:

Hexarelin modulates liver enzyme activity involved in lipid metabolism, reducing triglyceride accumulation and improving cholesterol balance. By activating peroxisome proliferator-activated receptor alpha (PPAR-α), it enhances lipid oxidation and fat metabolism, supporting cardiovascular health and reducing atherosclerosis risk.

Muscle Preservation:

Hexarelin stimulates myogenesis by activating the mechanistic target of rapamycin (mTOR) pathway, promoting muscle protein synthesis and hypertrophy. It also inhibits myostatin, a negative regulator of muscle growth, allowing for greater skeletal muscle repair and regeneration.

Consider Stacking With

- Any GHRH (CJC-1295, MOD-GRF-1295, Tesamorelin)

- BPC-157

- TB-4

- AOD-9604

- Semaglutide/Tirzepatide

- PEG-MGF

- Kisspeptin-10

- 5-Amino-1MQ

Side Effects & Cautions

Common Side Effects

- Injection site redness, itchiness, swelling

- Increased appetite (less than GHRP-2/6)

- Water retention

- Desensitization with prolonged use

- Mild edema

Cautions

- Avoid with hormone-sensitive conditions (e.g., prolactinomas)

- Use caution in cardiovascular disease pending further research

Research & References

Research Highlights

Cardiac Protection (2002): Hexarelin reduced cardiac fibrosis and apoptosis in animal models post-heart attack. (Source: PMID 12473550)

Muscle Preservation (2011): Prevented muscle wasting and supported recovery in cachexia and sarcopenia models. (Source: PMID 22005308)

Lipid Metabolism (2001): Improved cholesterol profiles and reduced triglyceride levels in clinical trials. (Source: PMID 11522130)

GH Secretion Potency (1999): Demonstrated the strongest GH release among GHRPs in comparative studies. (Source: PMID 10211492)

References

Cardioprotective Effects of Hexarelin - Published: 2002 (PMID 12473550)

Hexarelin in Muscle Wasting Conditions - Published: 2011 (PMID 22005308)

Impact of Hexarelin on Lipid Metabolism - Published: 2001 (PMID 11522130)

Hexarelin and GH Secretion Dynamics - Published: 1999 (PMID 10211492)